" class="no-js "lang="en-US"> Neurofenix - Medtech Alert
Friday, March 29, 2024
Neurofenix | Pharmtech Focus

Neurofenix

About Neurofenix

Neurofenix

Neurofenix is an innovative digital therapeutics company empowering patients and their families to get their life back after suffering a stroke, traumatic brain injury or spinal cord injury. Our global team of highly motivated professionals includes bio-medical engineers, occupational therapists, software engineers and others. Many of us have personal experiences with neurological injuries, which inspire us in our day-to-day work. Neurofenix closed its Series A round of investment in August 2022, and is actively selling the NeuroBall platform to survivors, rehabilitation clinics and institutions for upper extremity recovery.

Related Story

Digital Rehabilitation Platform Neurofenix Completes $7 Million Series A to Transform Stroke and Brain Injury Recovery

August 31 2022

Neurofenix, the neurological rehabilitation platform that uses sensors to improve patient outcomes, has raised $7 million in […]